• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺神经内分泌肿瘤预后因素的 Meta 分析。

A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms.

机构信息

Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China.

Pancreas Institute of Nanjing Medical University, Nanjing, 210029, People's Republic of China.

出版信息

Sci Rep. 2018 May 8;8(1):7271. doi: 10.1038/s41598-018-24072-0.

DOI:10.1038/s41598-018-24072-0
PMID:29739948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5940798/
Abstract

Pancreatic neuroendocrine neoplasms (pNENs) are a group of clinically rare and heterogeneous diseases of the pancreas. However, the prognostic factors for this disease in patients still remain controversial. The purpose of our study is to evaluate the predictive roles of those prognostic factors for pNENs. All related articles published until Sep 17, 2017 were identified via PubMed, EMBASE, Web of Science, Ovid and the Cochrane Library. Studies that examined the prognostic factors of pNENs were enrolled. 17 articles (2822 patients) were finally included in this study. The pooled data suggested that patients with positive surgical resection margin and lymph node, advanced G stage and TMN stage, organ metastasis, vascular invasion and the necrosis of specimens had a decreased overall survival for pNENs. Similarly, patients with functional tumors might have a poor prognosis. However, age, gender, surgical type and size of tumor could not be regarded as prognostic factors for pNENs. Our analytic data demonstrated that surgical resection margin, G stage, TMN stage, lymph node, metastasis, vascular invasion and the necrosis could be prognostic factors for pNENs. Our study may assist doctors to screen patients with different prognosis more efficiently during follow-up and select appropriate treatment measures.

摘要

胰腺神经内分泌肿瘤(pNENs)是一组临床上罕见且具有异质性的胰腺疾病。然而,该疾病患者的预后因素仍存在争议。我们的研究旨在评估这些预后因素对 pNENs 的预测作用。通过 PubMed、EMBASE、Web of Science、Ovid 和 Cochrane Library 检索截至 2017 年 9 月 17 日发表的所有相关文章。纳入了研究 pNENs 预后因素的研究。最终共有 17 篇文章(2822 例患者)纳入本研究。汇总数据表明,pNENs 患者的手术切缘阳性、淋巴结阳性、G 分期和 TMN 分期较晚、器官转移、血管侵犯和标本坏死与总体生存率降低相关。同样,功能性肿瘤患者可能预后不良。然而,年龄、性别、手术类型和肿瘤大小不能作为 pNENs 的预后因素。我们的分析数据表明,手术切缘、G 分期、TMN 分期、淋巴结、转移、血管侵犯和坏死可能是 pNENs 的预后因素。我们的研究可以帮助医生在随访期间更有效地筛选具有不同预后的患者,并选择合适的治疗措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8756/5940798/7055abbb97ea/41598_2018_24072_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8756/5940798/cbc65a384985/41598_2018_24072_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8756/5940798/ee244bedf79c/41598_2018_24072_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8756/5940798/7055abbb97ea/41598_2018_24072_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8756/5940798/cbc65a384985/41598_2018_24072_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8756/5940798/ee244bedf79c/41598_2018_24072_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8756/5940798/7055abbb97ea/41598_2018_24072_Fig3_HTML.jpg

相似文献

1
A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms.胰腺神经内分泌肿瘤预后因素的 Meta 分析。
Sci Rep. 2018 May 8;8(1):7271. doi: 10.1038/s41598-018-24072-0.
2
Predictive Effect of the Total Number of Examined Lymph Nodes on N Staging and Survival in Pancreatic Neuroendocrine Neoplasms.检查淋巴结总数对胰腺神经内分泌肿瘤N分期及生存的预测作用
Pancreas. 2018 Feb;47(2):183-189. doi: 10.1097/MPA.0000000000000987.
3
Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide study.小胰腺神经内分泌肿瘤的恶性潜能及其危险因素:一项全国多中心研究。
Pancreatology. 2021 Jan;21(1):208-214. doi: 10.1016/j.pan.2020.11.016. Epub 2020 Dec 1.
4
Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.比较胰腺神经内分泌肿瘤和胰腺导管腺癌淋巴结转移的形态学特征。
Pancreatology. 2020 Jul;20(5):936-943. doi: 10.1016/j.pan.2020.05.013. Epub 2020 May 22.
5
The number of positive lymph node is a better predictor of survival than the lymph node metastasis status for pancreatic neuroendocrine neoplasms: A retrospective cohort study.阳性淋巴结数量比淋巴结转移状态更能预测胰腺神经内分泌肿瘤的生存情况:一项回顾性队列研究。
Int J Surg. 2017 Dec;48:142-148. doi: 10.1016/j.ijsu.2017.10.064. Epub 2017 Nov 6.
6
Overestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas.胰腺左侧G1无功能神经内分泌肿瘤中淋巴结转移的肿瘤学意义被高估
Medicine (Baltimore). 2015 Sep;94(36):e1404. doi: 10.1097/MD.0000000000001404.
7
Clinicoradiological Factors Predicting Lymph Node Metastasis in Patients with Nonfunctioning Pancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis.临床与影像学因素预测无功能性胰腺神经内分泌肿瘤患者淋巴结转移的系统评价和 Meta 分析。
Neuroendocrinology. 2024;114(2):111-119. doi: 10.1159/000534029. Epub 2023 Sep 13.
8
Meta-Analysis of Prognostic Factors for Recurrence of Resected Well-Differentiated Pancreatic Neuroendocrine Tumors.胰腺高分化神经内分泌肿瘤切除术后复发的预后因素的Meta分析
Neuroendocrinology. 2021;111(12):1231-1237. doi: 10.1159/000514047. Epub 2020 Dec 28.
9
Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study group.探索奥地利胰腺神经内分泌肿瘤的手术现状:ASSO pNEN 研究组的结果。
Eur J Surg Oncol. 2019 Feb;45(2):198-206. doi: 10.1016/j.ejso.2018.08.016. Epub 2018 Sep 3.
10
The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.2cm 以下胰腺神经内分泌肿瘤的难题:预测淋巴结转移和指导手术管理的术前风险评分。
Surgery. 2019 Jul;166(1):15-21. doi: 10.1016/j.surg.2019.03.008. Epub 2019 May 6.

引用本文的文献

1
The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy.PANEN列线图:为接受肽受体放射性核素治疗的转移性胰腺神经内分泌肿瘤患者提供临床决策支持。
Front Endocrinol (Lausanne). 2025 Jun 24;16:1514792. doi: 10.3389/fendo.2025.1514792. eCollection 2025.
2
Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group.淋巴结阴性胰腺神经内分泌肿瘤中淋巴管侵犯的发生率及预后意义:美国神经内分泌研究组的结果
J Surg Oncol. 2025 Mar;131(3):465-472. doi: 10.1002/jso.27914. Epub 2024 Oct 13.
3

本文引用的文献

1
Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center.可手术切除的胰腺神经内分泌肿瘤长期预后的预测因素:来自单一中心的12年经验
Oncol Lett. 2017 Mar;13(3):1157-1164. doi: 10.3892/ol.2017.5561. Epub 2017 Jan 2.
2
Pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤
Intractable Rare Dis Res. 2017 Feb;6(1):21-28. doi: 10.5582/irdr.2017.01007.
3
Significance of lymph node metastasis in pancreatic neuroendocrine tumor.胰腺神经内分泌肿瘤中淋巴结转移的意义
Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 Patients.
胰腺神经内分泌肿瘤患者的无复发生存率和疾病特异性生存率:一项针对413例患者的单中心回顾性研究
Cancers (Basel). 2023 Dec 24;16(1):100. doi: 10.3390/cancers16010100.
4
Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms.高分化无功能胰腺神经内分泌肿瘤患者的最佳淋巴结清扫术
J Clin Med. 2023 Oct 26;12(21):6778. doi: 10.3390/jcm12216778.
5
Preoperative prediction of pancreatic neuroendocrine tumor grade based on Ga-DOTATATE PET/CT.基于 Ga-DOTATATE PET/CT 的胰腺神经内分泌肿瘤分级术前预测。
Endocrine. 2024 Feb;83(2):502-510. doi: 10.1007/s12020-023-03515-3. Epub 2023 Sep 16.
6
Comment on "Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort".关于“大型多中心队列中直径<3 cm的无功能性胰腺神经内分泌肿瘤患者的保留实质和肿瘤切除的长期结局”的评论
Ann Surg Open. 2023 Mar 14;4(1):e266. doi: 10.1097/AS9.0000000000000266. eCollection 2023 Mar.
7
Pancreatic neuroendocrine neoplasms: survival trend analysis of a comprehensive center.胰腺神经内分泌肿瘤:一个综合中心的生存趋势分析
Endocr Oncol. 2022 Apr 21;2(1):32-41. doi: 10.1530/EO-22-0043. eCollection 2022 Jan.
8
A Machine Learning Approach Using [F]FDG PET-Based Radiomics for Prediction of Tumor Grade and Prognosis in Pancreatic Neuroendocrine Tumor.一种基于[F]FDG PET的放射组学的机器学习方法用于预测胰腺神经内分泌肿瘤的肿瘤分级和预后
Mol Imaging Biol. 2023 Oct;25(5):897-910. doi: 10.1007/s11307-023-01832-7. Epub 2023 Jul 3.
9
Predicting the survival of patients with pancreatic neuroendocrine neoplasms using deep learning: A study based on Surveillance, Epidemiology, and End Results database.使用深度学习预测胰腺神经内分泌肿瘤患者的生存情况:基于监测、流行病学和最终结果数据库的研究。
Cancer Med. 2023 Jun;12(11):12413-12424. doi: 10.1002/cam4.5949. Epub 2023 May 11.
10
Early-onset pancreatic neuroendocrine neoplasms: A distinct disease with improved survival compared with old individuals.早发性胰腺神经内分泌肿瘤:与老年患者相比,这种疾病具有独特的特征,生存情况得到改善。
Front Endocrinol (Lausanne). 2023 Apr 4;14:1025485. doi: 10.3389/fendo.2023.1025485. eCollection 2023.
Surg Today. 2017 Sep;47(9):1104-1110. doi: 10.1007/s00595-017-1485-y. Epub 2017 Feb 22.
4
Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors.无症状和有症状非功能性胰腺神经内分泌肿瘤的手术预后监测和比较。
Int J Surg. 2017 Mar;39:127-134. doi: 10.1016/j.ijsu.2017.01.088. Epub 2017 Jan 27.
5
Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.胰腺神经内分泌肿瘤:基础生物学、当前治疗策略及未来展望
Int J Mol Sci. 2017 Jan 13;18(1):143. doi: 10.3390/ijms18010143.
6
Pancreatic Neuroendocrine Tumors.胰腺神经内分泌肿瘤
Surg Pathol Clin. 2016 Dec;9(4):595-617. doi: 10.1016/j.path.2016.05.006. Epub 2016 Oct 12.
7
Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes.100例可切除胰腺神经内分泌肿瘤的连续病例分析:临床病理特征及长期预后
Front Med. 2016 Dec;10(4):444-450. doi: 10.1007/s11684-016-0471-x. Epub 2016 Dec 23.
8
A single institution's 21-year experience with surgically resected pancreatic neuroendocrine tumors: an analysis of survival and prognostic factors.一家机构21年手术切除胰腺神经内分泌肿瘤的经验:生存及预后因素分析
Rev Esp Enferm Dig. 2016 Nov;108(11):689-696. doi: 10.17235/reed.2016.4323/2016.
9
A short history of neuroendocrine tumours and their peptide hormones.神经内分泌肿瘤及其肽类激素简史。
Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):3-17. doi: 10.1016/j.beem.2015.10.004. Epub 2015 Oct 23.
10
Epidemiology, diagnosis, surgical treatment and prognosis of the pancreatic neuroendocrine tumors: Report of 125 patients from one single center.胰腺神经内分泌肿瘤的流行病学、诊断、外科治疗及预后:来自单一中心的125例患者报告
Indian J Cancer. 2015 Jul-Sep;52(3):343-9. doi: 10.4103/0019-509X.176746.